102 results
Page 3 of 6
6-K
EX-99.1
5vgw29ijvx50jh
23 Jun 22
Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies
11:21am
6-K
EX-99.1
i1zw90ik 81i
6 May 22
Current report (foreign)
5:18pm
6-K
EX-99.2
i1733fgg yem1t7
6 May 22
Current report (foreign)
5:18pm
6-K
EX-99.2
95myi97afjkft90leobe
11 Apr 22
Current report (foreign)
5:14pm
6-K
EX-99.3
bc1jd575tmcv
11 Apr 22
Current report (foreign)
5:14pm
6-K
EX-99.1
p62nl5e
28 Mar 22
Jyseleca® approved in Japan for ulcerative colitis
1:50pm
6-K
EX-99.6
4mfikhj4
24 Mar 22
Galapagos publishes 2021 annual report and announces Biographies of proposed new board members
8:13pm
6-K
EX-99.1
8w4kjpi6 gr
24 Mar 22
Galapagos publishes 2021 annual report and announces Biographies of proposed new board members
8:13pm
6-K
EX-99.4
pye8wd5r09iqxxu
24 Mar 22
Galapagos publishes 2021 annual report and announces Biographies of proposed new board members
8:13pm
6-K
EX-99.1
4cje08xm3xpy gqif
24 Feb 22
Galapagos 2021 results set stage for future growth
5:19pm
6-K
EX-99.1
17ckryy
27 Jan 22
Galapagos appoints Paul Stoffels as Chief Executive Officer
12:00am
6-K
EX-99.1
g9awrq8froluksxcu2b0
8 Nov 21
Galapagos reports commercial and operational progress at Q3 financial results
4:03pm
6-K
EX-99.2
oko6693co1nzw
8 Nov 21
Galapagos reports commercial and operational progress at Q3 financial results
4:03pm
6-K
EX-99.1
u6vkq
31 Aug 21
Galapagos announces planned retirement of CEO
3:46pm
6-K
EX-99.1
x6b1r
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
EX-99.2
k2209sqv 9y92l
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
EX-99.1
ewdcoai0w9shfbyz5
23 Jun 21
Galapagos announces departure of CSO Piet Wigerinck later this year
6:00am
6-K
EX-99.1
t4ycsv7e
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.2
vjod84kxmtap4gvcrj
11 May 21
Current report (foreign)
2:10pm